乐虎lehu国际

Uni-Bio Science Group’s Uni-GLP Developmental Potential in Treatment of COVID-19 and Other Indications

2020-09-18

View details

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration, Accelerating the Progress of 2 nd Generation Uni-PTH Launch

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration,Accelerating the Progress of 2 nd Generation Uni-PTH Launch

2020-09-04

View details

2020 Interim Results: Operating Profit From Marketed Pharmaceutical Products Recorded an Increase of 126.6%, Expanding R&D Activity in Antibody Drug Development to Diversify Product Portfolio

2020-08-28

View details

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

2020-07-15

View details

Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce

2020-05-14

View details

1...
<<
4
5
6
7
8
>>
16

Hot news

<dd id='jnwkw'></dd>

乐虎lehu国际

Media

PRESS RELEASES

Uni-Bio Science Group’s Uni-GLP Developmental Potential in Treatment of COVID-19 and Other Indications

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration, Accelerating the Progress of 2 nd Generation Uni-PTH Launch

2020 Interim Results: Operating Profit From Marketed Pharmaceutical Products Recorded an Increase of 126.6%, Expanding R&D Activity in Antibody Drug Development to Diversify Product Portfolio

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce

Copyright ©2024 Uni-Bio Science Group Ltd.

乐虎lehu国际

Media

PRESS RELEASES

Uni-Bio Science Group’s Uni-GLP Developmental Potential in Treatment of COVID-19 and Other Indications

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration, Accelerating the Progress of 2 nd Generation Uni-PTH Launch

2020 Interim Results: Operating Profit From Marketed Pharmaceutical Products Recorded an Increase of 126.6%, Expanding R&D Activity in Antibody Drug Development to Diversify Product Portfolio

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce

Copyright ©2024 Uni-Bio Science Group Ltd.

Uni-Bio Science Group’s Uni-GLP Developmental Potential in Treatment of COVID-19 and Other Indications

Uni-Bio Science Group Receives IND Approval for Uni-PTH Liquid Injection by the National Medical Products Administration, Accelerating the Progress of 2 nd Generation Uni-PTH Launch

2020 Interim Results: Operating Profit From Marketed Pharmaceutical Products Recorded an Increase of 126.6%, Expanding R&D Activity in Antibody Drug Development to Diversify Product Portfolio

Uni-Bio Science (00690.HK)'s Uni-GLP Injection Clinical Trial Application Accepted by National Medical Products Administration

Uni-Bio Science Group and Medlink Builds Strategic Partnership,Expansion of Value Chain towards Pharmaceutical E-commerce